文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

Knowledge structure and dynamic evolution of nanomedicine in liver cancer research: a scientometric analysis and visualization.

作者信息

Li Shaodong, Cui Dapeng, Shao Bo, Kang Zhenhua, Yan Guoqiang

机构信息

Department of Hepatobiliary and Pancreatic Surgery, General Surgery Center, The First Hospital of Jilin University, Changchun, China.

Department of General Surgery, The First Affiliated Hospital of Hebei North University, Zhangjiakou, China.

出版信息

Front Pharmacol. 2025 Feb 26;16:1509259. doi: 10.3389/fphar.2025.1509259. eCollection 2025.


DOI:10.3389/fphar.2025.1509259
PMID:40078283
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11897278/
Abstract

BACKGROUND: Nanomedicine has received much attention for its potential applications in the diagnosis and treatment of liver cancer. However, no bibliometric evaluation has been conducted to present an assessment of scientific progress in the field. The aim of this study is to comprehensively catalog the cooperation and influence of journals, countries, institutions, and authors in the field of nanomedicine in liver cancer from the perspective of bibliometrics, evaluate the clustering evolution of knowledge structure, and uncover hot topics and emerging themes. METHODS: Articles and reviews related to nanomedicine and liver cancer were retrieved from the Web of Science Core Literature Library using Topic Search. #1 T= ("Hepatic Neoplasm*" OR "Liver Neoplasm" OR "Liver Cancer*" OR "Hepatocellular Cancer*" OR "Hepatic Cancer*"), #2 T= "nano*", the search strategy is set as #1 AND #2 limited to Science Citation Index Expanded database source, with no limitation of publication types and language/time. Bibliometric studies were conducted using CiteSpace and VOSviewer. RESULTS: 2,648 articles and reviews were included from 2000 to 2024. The number of articles regarding nanomedicine in liver cancer showed an increasing trend. Analysis of the most productive journals shows that most are specialized in nanoscience and nanotechnology, pharmacology and pharmacy, and chemistry and multidisciplinary. These publications mainly come from 8,782 institutions in 297 countries led by China and the United States of America. Shao D published the most papers among the publications, while Jemal A had the most co-citations. The macroscopical sketch and micro-representation of the whole knowledge field are realized through co-citation analysis. Hepatocellular carcinoma, targeted delivery, sorafenib nanoparticles, and others are current and developing areas of study. The keywords "nanocrystals," "biodistribution," and "particles" also may be the focus of new trends and future research. CONCLUSION: In this study, bibliometrics and visual methods were used to review the research of nanomedicine in liver cancer comprehensively. The article will help scholars to gain a better understanding of the dynamic evolution of nanomedicine applications in liver cancer and point the directions for future research.

摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0201/11897278/b20c45f412b2/fphar-16-1509259-g010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0201/11897278/4710a9fcbdf6/fphar-16-1509259-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0201/11897278/66a86e8a3f8b/fphar-16-1509259-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0201/11897278/559319992591/fphar-16-1509259-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0201/11897278/deed5f641f31/fphar-16-1509259-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0201/11897278/5d91863b935f/fphar-16-1509259-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0201/11897278/c75a5a0a029e/fphar-16-1509259-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0201/11897278/1157804c6c7e/fphar-16-1509259-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0201/11897278/c9273ec27690/fphar-16-1509259-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0201/11897278/fc5cbc01e6e1/fphar-16-1509259-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0201/11897278/b20c45f412b2/fphar-16-1509259-g010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0201/11897278/4710a9fcbdf6/fphar-16-1509259-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0201/11897278/66a86e8a3f8b/fphar-16-1509259-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0201/11897278/559319992591/fphar-16-1509259-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0201/11897278/deed5f641f31/fphar-16-1509259-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0201/11897278/5d91863b935f/fphar-16-1509259-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0201/11897278/c75a5a0a029e/fphar-16-1509259-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0201/11897278/1157804c6c7e/fphar-16-1509259-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0201/11897278/c9273ec27690/fphar-16-1509259-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0201/11897278/fc5cbc01e6e1/fphar-16-1509259-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0201/11897278/b20c45f412b2/fphar-16-1509259-g010.jpg

相似文献

[1]
Knowledge structure and dynamic evolution of nanomedicine in liver cancer research: a scientometric analysis and visualization.

Front Pharmacol. 2025-2-26

[2]
Structural and Temporal Dynamics of Mesenchymal Stem Cells in Liver Diseases From 2001 to 2021: A Bibliometric Analysis.

Front Immunol. 2022

[3]
Bibliometric study of immunotherapy for hepatocellular carcinoma.

Front Immunol. 2023

[4]
Bibliometric and visual analysis of intestinal ischemia reperfusion from 2004 to 2022.

Front Med (Lausanne). 2022-8-15

[5]
Research Trends in the Application of Artificial Intelligence in Oncology: A Bibliometric and Network Visualization Study.

Front Biosci (Landmark Ed). 2022-8-31

[6]
Bibliometric and visualized analysis of cancer nanomedicine from 2013 to 2023.

Drug Deliv Transl Res. 2024-6

[7]
Immunological factors in cirrhosis diseases from a bibliometric point of view.

World J Gastroenterol. 2023-6-28

[8]
Research hotspots and frontiers of machine learning in renal medicine: a bibliometric and visual analysis from 2013 to 2024.

Int Urol Nephrol. 2025-3

[9]
Mapping knowledge landscapes and emerging trends of the links between osteoarthritis and osteoporosis: A bibliometric analysis.

Front Public Health. 2022

[10]
Enhanced recovery after surgery from 1997 to 2022: a bibliometric and visual analysis.

Updates Surg. 2024-8

本文引用的文献

[1]
Global research on nanomaterials for liver cancer from 2004 to 2023: a bibliometric and visual analysis.

Discov Oncol. 2024-12-26

[2]
Fluorescent probe applications and prospects in gastrointestinal cancer: A bibliometric analysis.

Eur J Surg Oncol. 2024-10

[3]
Applications of 3D organoids in toxicological studies: a comprehensive analysis based on bibliometrics and advances in toxicological mechanisms.

Arch Toxicol. 2024-8

[4]
Bibliometric analysis and systematic review of electrochemical methods for environmental remediation.

J Environ Sci (China). 2024-10

[5]
Research trends on nanomaterials in gastric cancer: a bibliometric analysis from 2004 to 2023.

J Nanobiotechnology. 2023-8-2

[6]
Sorafenib-Loaded PLGA Carriers for Enhanced Drug Delivery and Cellular Uptake in Liver Cancer Cells.

Int J Nanomedicine. 2023

[7]
Functional materials of 3D bioprinting for wound dressings and skin tissue engineering applications: A review.

Int J Bioprint. 2023-3-18

[8]
Nanotechnology-General Aspects: A Chemical Reduction Approach to the Synthesis of Nanoparticles.

Molecules. 2023-6-22

[9]
Nano Ultrasound Contrast Agent for Synergistic Chemo-photothermal Therapy and Enhanced Immunotherapy Against Liver Cancer and Metastasis.

Adv Sci (Weinh). 2023-7

[10]
Effective Cancer Management: Inimitable Role of Phytochemical Based Nano- Formulations.

Curr Drug Metab. 2022

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索